Skip to content

Adaptix™ Interbody System with Titan nanoLOCK™ Surface Technology 84332813Recalls & reported problems

Medtronic Sofamor Danek, Inc. · SPACER 84332813 ADAPTIX 28MM X 13MM · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00763000203030), received between May 21, 2026 and May 21, 2026 — classified as 1 malfunction.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 1 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Migration1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 21, 2026Migration

    INFORMATION WAS RECEIVED FROM MULTIPLE SOURCES (MANUFACTURER REPRESENTATIVE, HEALTHCARE PROVIDER, CLINICAL STUDY) REGARDING A PATIENT WITH CLINICAL ID: (B)(6) AND STUDY NAME AND NUMBER TLIF IDE PIVOTAL - (B)(6). IT WAS REPORTED THAT AN INTERBODY IMPLANT SUBSIDENCE AT THE 12-MONTH FOLLOW-UP WAS IDENTIFIED IN THE PATIENT. THE INVESTIGATOR HAS NOT REPORTED SUBSIDENCE FOR THIS SUBJECT. NO FURTHER COMPLICATEIONS REPORTED REGARDING THE EVENT. ADDITIONAL INFORMATION RECEIVED FROM MANUFACTURER REPRESENTATIVE STATING THAT IT WAS UNKNOWN IF THERE WAS ANY REVISION SURGERY PERFORMED OR ANY FUTURE REVISION TO EXPLANT THE SUBSIDED IMPLANT. THERE WERE NO PATIENT SYMPTOMS REPORTED AS A RESULT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25240591 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page